Darifenacin, a muscarinic receptor antagonist with selectivity for M3 receptors, reduces incontinence and nocturia in patients with overactive bladder
Hill S1, Khullar V2 1. Department of Obstetrics and Gynaecology, Queen's Park Hospital, Blackburn, UK, 2. St Mary's NHS Trust (Imperial College, London), London, UK
|
|
Abstract 145
|
|
|
Clinical Pharmacology and Overactivity - Blue Room:Chaired by Harold Drutz and Alan Wein
Scientific Podium Poster Session 16
|
|
|
Friday 27th August 2004 |
|
|
14:46 - 14:53 |
|
|